Format

Send to

Choose Destination
Eur Neuropsychopharmacol. 2011 Feb;21(2):180-91. doi: 10.1016/j.euroneuro.2010.08.002.

Costs of illness and care in Parkinson's disease: an evaluation in six countries.

Author information

1
Department of Neurology, Philipps University Marburg, Rudolf-Bultmann-Strasse 8, Marburg, Germany.

Abstract

We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

Comment in

PMID:
20888737
DOI:
10.1016/j.euroneuro.2010.08.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center